Predictive factors for non-sentinel lymph node metastasis in patients with ACOSOG Z0011 criteria

CM Loza, P Mandó, C Ponce, F Coló, V Fabiano… - Breast Care, 2018 - karger.com
Background: Nodal staging constitutes an element of great importance in the treatment
planning for early breast cancer. The ACOSOG Z0011 trial demonstrated that sentinel lymph …

Axillary lymph node and non-sentinel lymph node metastasis among the ACOSOG Z0011 eligible breast cancer patients with invasive ductal, invasive lobular, or other …

W Gao, Y Zeng, X Fei, X Chen, K Shen - Breast Cancer Research and …, 2020 - Springer
Purpose Given the histological special types (HST) of breast carcinoma accounted for
minority of the Z0011 study population, this study aimed to assess the rates of axillary lymph …

Non-sentinel axillary tumor burden applying the ACOSOG Z0011 eligibility criteria to a large routine cohort

F Riedel, J Heil, M Feißt, M Rezai, M Moderow… - Breast Cancer Research …, 2019 - Springer
Abstract Purpose In the ACOSOG Z0011 trial, patients with primary breast cancer (BC) and 1–
2 tumor-involved sentinel lymph nodes (SLN) undergoing breast-conserving surgery gained …

Should ACOSOG Z0011 change practice with respect to axillary lymph node dissection for a positive sentinel lymph node biopsy in breast cancer?

AE Giuliano, M Morrow, S Duggal, TB Julian - Clinical & experimental …, 2012 - Springer
While any study can be criticized, the results of Z0011 clearly show that sentinel lymph node
biopsy (SLNB) alone without axillary lymph node dissection (ALND) results in extremely low …

Impact of axillary dissection in women with invasive breast cancer who do not fit the Z0011 ACOSOG trial because of three or more metastatic sentinel lymph nodes

C Bonneau, D Hequet, JP Estevez, N Pouget… - European Journal of …, 2015 - Elsevier
Aim The objective of this study was to determine the effects of axillary lymph node dissection
(ALND) versus sentinel lymph node biopsy alone (SLNB) on the survival of patients with 3 or …

Ten-year survival results of ACOSOG Z0011: A randomized trial of axillary node dissection in women with clinical T1-2 N0 M0 breast cancer who have a positive …

AE Giuliano, K Hunt, KV Ballman, PD Beitsch… - 2016 - ascopubs.org
1007 Background: The early results of ACOSOG Z0011 showed that selected sentinel node
(SN)-positive patients (pts) treated with sentinel node biopsy (SNB), whole breast irradiation …

ACOSOG Z0011: A randomized trial of axillary node dissection in women with clinical T1-2 N0 M0 breast cancer who have a positive sentinel node.

AE Giuliano, LM McCall, PD Beitsch… - Journal of Clinical …, 2010 - ascopubs.org
CRA506 Background: Sentinel node biopsy (SNB) eliminates the need for axillary dissection
(ALND) in patients whose sentinel node (SN) is tumor-free. However, completion ALND …

Evaluation of sentinel lymph node biopsy and axillary lymph node dissection for breast cancer treatment concepts-a retrospective study of 1,214 breast cancer patients

RG Stein, R Fricker, T Rink, H Fitz, S Blasius… - Breast Care, 2017 - karger.com
Background: Most breast cancer patients require lumpectomy with axillary sentinel lymph
node biopsy (SLNB) or axillary lymph node dissection (ALND). The ACOSOG Z0011-trial …

Sentinel Node Biopsy in Patients With Breast Carcinoma Without Axillary Involvement at Diagnosis Receiving Primary Systemic Therapy

L García-Calvo, CM Álvarez, AH Gutiérrez… - Clinical Breast …, 2023 - Elsevier
Background Primary systemic therapy (PST) has acquired great importance in breast cancer
(BC) in the last few years. In this scenario, even if it is accepted to perform SLNB before PST …

[PDF][PDF] Factors predicting non-sentinel lymph node metastasis in T1-2 invasive breast cancer with 1-2 axillary sentinel lymph node metastases: Presentation of …

B Kuru, Y Sullu, S Yuruker, I Koray Bayrak, N Ozen - J BUON, 2016 - jbuon.com
Purpose: To evaluate the predicting factors for non-sentinel lymph node (SLN) metastases in
T1-2 invasive breast cancer with 1-2 metastatic SLN that fully matched the ACOSOG Z0011 …